New to The Street TV Spotlights Synergy CHC (NASDAQ:SNYR) as Former Coca-Cola Executive Joins to Drive FOCUSfactor(R) Energy Drink's Global Expansion
NEW YORK, NY / ACCESS Newswire New to The Street, the nationally televised business show airing on Bloomberg and FOX Business, proudly features Synergy CHC Corp. (NASDAQ:SNYR) as a spotlight company, highlighting the brand's strategic expansion in the global functional beverage market. The feature follows Synergy's high-profile appointment of Damian Marano, a former Coca-Cola executive, as the company's new Vice President of Beverage.
Marano, a seasoned global brand architect with over 20 years at Coca-Cola and founder of Docklight Brands, joins Synergy CHC to lead the international rollout of its FOCUSfactor® Energy Drink, a fast-emerging player in the $30B+ clean-energy beverage space.
'New to The Street's mission has always been to introduce audiences to the most dynamic companies shaping tomorrow's economy,' said Jane King, anchor at New to The Street. 'Synergy's aggressive expansion strategy, coupled with leadership from a Coca-Cola veteran, puts them in a strong position to disrupt the functional beverage category.'
FOCUSfactor® Energy Drink is powered by brain-boosting nootropics and essential vitamins, building on the brand equity of Synergy's best-selling FOCUSfactor® supplement line, currently sold in major retailers like Costco, Amazon, Walmart, CVS, and Walgreens.
Damian Marano commented, 'Having led growth initiatives for some of the world's most recognizable beverage brands, I see a massive opportunity in FOCUSfactor® to define the next wave of clean, functional performance drinks.'
The appointment follows the recent addition of Erik Shields to Synergy's beverage team and aligns with the company's strategy to scale its consumer health portfolio globally.
The New to The Street feature will air on Bloomberg TV this Saturday at 6:30 PM ET and FOX Business next week, with segments available on YouTube and social platforms to more than 2.5 million subscribers.
About Synergy CHC Corp.
Synergy CHC Corp. (NASDAQ: SNYR) is a consumer health and wellness company marketing a portfolio of trusted brands including FOCUSfactor®, Flat Tummy®, Sneaky Vaunt®, and Hand MD®. With a footprint in North America, Canada, and the UK, Synergy is focused on driving innovation across supplements, beauty, and functional beverages. Learn more at www.synergychc.com.
About New to The Street
New to The Street is one of the longest-running business television brands in the U.S., broadcasting sponsored content on FOX Business, Bloomberg, and through over 2.5 million YouTube subscribers. The show features innovative public and private companies delivering news, insights, and investment perspectives across global markets.
Media Contacts:
Monica Brennan
New to The Street Media Relations
Monica@NewToTheStreet.com
Investor Relations
Synergy CHC Corp.
ir@synergychc.com
SOURCE: New To The Street
View the original press release on ACCESS Newswire
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
S&P 500 ends lower; traders focus on Middle East tension
STORY: U.S. stocks ended lower on Wednesday, with the Dow unchanged, the S&P 500 slipping a quarter of one percent, and the Nasdaq losing half of one percent. Wall Street erased modest gains as tensions flared in the Middle East. Sources said the U.S. was preparing a partial evacuation of its embassy in Iraq, after a senior Iranian official said Tehran will strike U.S. bases in the region if nuclear negotiations fail and if conflict arises with the United States. Investors also awaited more details on trade talks between the U.S. and China after President Donald Trump said a deal was (quote) "done," with Beijing to supply magnets and rare earth minerals. But amid the trade developments and geopolitical tensions, BMO Chief Market Strategist Carol Schleif says the stock market continues to show resilience. 'It's clearly a market that wants to look through the short term, whether it's exhausted or not, but it wants to look through short term noise and and stick with the long term fundamentals. And the fact is is the fundamentals keep coming through solidly. You know people thought we'd see more inflation out of today's CPI report and it's not being passed on. I think companies are either- They either stocked up, they're figuring out how to absorb some of it or and or they understand that consumers are just the consumers, have had it with inflation. And so, there's a big risk to passing it on.' The latest data on consumer prices showed they increased only marginally in May, while economists expect inflation to accelerate in the coming months due to the Trump administration's import tariffs. Stocks on the move Wednesday included GameStop which fell more than 5% after the video game retailer reported a decline in first-quarter revenue. And shares of Starbucks added more than 4% after its CEO told the Financial Times that it received 'a lot of interest' for its China business. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
28 minutes ago
- Yahoo
Moxie and Revision Skincare® Announce Strategic Partnership to Empower High-Growth Medspas
Streamlined Ordering and Exclusive Education Now Available to Moxie-Supported Practices BROOKLYN, N.Y., June 11, 2025 /PRNewswire/ -- Moxie, the growth engine supporting over 400 aesthetic practices nationwide, today announced a strategic partnership with Revision Skincare®, the gold standard in science-backed, clinically proven skincare. This partnership brings Moxie-supported practices direct access to Revision's line of medical grade skincare, streamlined ordering, and elevated educational resources—all designed to drive profitability, operational efficiency, and exceptional client outcomes. "Independent medspas are the heartbeat of our specialty," said Kamau Massey, CEO of Moxie. "By partnering with Revision Skincare, we're expanding the ways in which we give our practices access to elite-tier products and business tools. It's about helping them compete—and win—at the highest level." This collaboration reflects a shared vision: empowering aesthetic entrepreneurs with the kind of brand alignment, service experience, and margin-boosting resources typically reserved for major enterprise clinics. "Our mission has always been to support skincare professionals with advanced innovation and education," said Joe Blahnik, Chief Sales Officer Revision Skincare®. "Moxie's commitment to the success of aesthetic practices mirrors our own—and together, we're making it easier than ever for providers to deliver exceptional results." This partnership is part of Moxie's ongoing commitment to building a best-in-class ecosystem for medspa success—uniting trusted brands that help independent practices grow, differentiate, and deliver exceptional patient experiences. About Moxie Moxie is the aesthetic practice growth and operating engine, helping medspa entrepreneurs reach multimillion dollar growth—with marketing, compliance, coaching, software, and VIP pricing, all in one place. From launch to scale, Moxie powers ambitious injectors and aesthetic entrepreneurs with the infrastructure, strategy, and partnerships they need to win in a competitive industry. About Revision Skincare® Revision Skincare® delivers high-performing, clinically validated skincare formulations rooted in rigorous research and testing. Trusted by professionals in over thirty countries across the globe, their award-winning products are designed to deliver real results—without compromising long-term skin health. Brandi EppolitoHead of MarketingMoxiebrandi@ This release was issued through WebWire®. For more information, visit View original content: SOURCE Moxie Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
37 minutes ago
- Yahoo
MacKenzie Realty Capital Completes The Refinancing of Loan for the Main Street West Property
ORINDA, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- MacKenzie Realty Capital, Inc. (Nasdaq: MKZR) ('MacKenzie' or the 'Company') is pleased to announce the successful refinancing of the Main Street West property in Napa, CA. The refinancing was completed with EverTrust Bank for approximately $9.5 million, a term for 3 years with a current interest rate of 7.5% (Prime). The Main Street West property is 40,000 square feet with retail and professional suites located at 1250 Main Street in downtown Napa. Robert Dixon, CEO and President of MacKenzie Realty Capital, said, "Despite many challenges in the current commercial real estate financing market, we continue to see lender appetite for well-located properties in solid markets. These complex transactions highlight the importance of long-term trusted lending relationships. EverTrust's deep in-house knowledge in structuring commercial real estate financing facilities has enabled us to close on a term sheet and underscores our proactive approach to managing our balance sheet and our dedication to driving long-term growth.' About MacKenzie Realty Capital, founded in 2013, is a West Coast-focused REIT that intends to invest at least 80% of its total assets in real property, and up to a maximum of 20% of its total assets in illiquid real estate securities. We intend for the real property portfolio to be approximately 50% multifamily and 50% boutique class A office. The Company has paid a dividend every year since inception. The current portfolio includes interests in 4 multifamily properties and 8 office properties plus 2 multifamily developments. For more information, please contact MacKenzie at (800) 854-8357. Please visit our website at: IR CONTACTAndrew Barwicki516-662-9461andrew@ Forward-Looking StatementsThis press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, our ability to remain financially healthy, and our expected future growth prospects. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. In some cases, forward-looking statements can be identified by the use of forward-looking terms such as 'anticipate,' 'estimate,' 'believe,' 'continue,' 'could,' 'intend,' 'may,' 'plan,' 'potential,' 'predict,' 'should,' 'will,' 'expect,' 'objective,' 'projection,' 'forecast,' 'goal,' 'guidance,' 'outlook,' 'effort,' 'target,' 'trajectory,' 'focus,' 'work to,' 'attempt,' 'pursue,' or the negative of these terms or other comparable terms. However, the absence of these words does not mean that the statements are not forward-looking. These forward-looking statements are based on certain assumptions and analyses made by us in light of our experience and our perception of historical trends, current conditions and expected future developments, as well as other factors we believe are appropriate in the circumstances. For a further discussion of factors that could cause our future results, performance, or transactions to differ significantly from those expressed in any forward-looking statement, please see the section titled 'Risk Factors' in annual reports on Form 10-K and quarterly reports on Form 10-Q that we file with the Securities and Exchange Commission from time to time. 89 Davis Road, Suite 100 • Orinda, California 94563 • Toll-Free (800) 854-8357 • Local (925) 631-9100 • in to access your portfolio
